Immix Biopharma (IMMX) Stock Chart & Stock Price History $1.66 +0.09 (+5.73%) Closing price 04/17/2025 03:57 PM EasternExtended Trading$1.67 +0.01 (+0.60%) As of 04/17/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Immix Biopharma Stock Price Performance 5 Day Performance+1.84%1 Month Performance-14.87%3 Month Performance-18.63%6 Month Performance-3.49%Year-To-Date Performance-24.55%1 Year Performance-24.20% Receive IMMX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Immix Biopharma and its competitors with MarketBeat's FREE daily newsletter. Email Address IMMX Stock Chart for Saturday, April, 19, 2025 IMMX Chart by TradingView Immix Biopharma Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/18/2025$1.66$1.66$1.69$1.6016,597 shs$46.02 million04/17/2025$1.57$1.66+5.73%$1.69$1.6016,597 shs$46.02 million04/16/2025$1.68$1.57-6.55%$1.74$1.5729,933 shs$43.52 million04/15/2025$1.63$1.68+3.07%$1.75$1.6419,393 shs$46.57 million04/14/2025$1.57$1.63+4.15%$1.75$1.5657,281 shs$45.19 million04/11/2025$1.46$1.57+6.97%$1.64$1.3648,976 shs$43.39 million04/10/2025$1.56$1.46-6.22%$1.49$1.4029,177 shs$40.56 million04/09/2025$1.36$1.56+14.71%$1.57$1.4058,630 shs$43.25 million04/09/2025$1.36$1.56+14.71%$1.57$1.4058,630 shs$43.25 million04/08/2025$1.51$1.36-9.93%$1.56$1.34109,944 shs$37.70 million Get the Latest News and Ratings for IMMX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Immix Biopharma and its competitors with MarketBeat's FREE daily newsletter. 04/08/2025$1.51$1.36-9.93%$1.56$1.34109,944 shs$37.70 million04/07/2025$1.50$1.51+0.67%$1.62$1.4547,597 shs$41.86 million04/04/2025$1.58$1.50-5.06%$1.65$1.5033,513 shs$41.58 million04/03/2025$1.65$1.58-4.24%$1.69$1.5718,654 shs$43.80 million04/02/2025$1.61$1.65+2.48%$1.72$1.5732,857 shs$45.74 million04/01/2025$1.68$1.61-4.17%$1.74$1.5549,335 shs$44.63 million03/31/2025$1.70$1.68-1.18%$1.75$1.36111,786 shs$46.57 million03/28/2025$1.71$1.70-0.58%$1.80$1.6624,157 shs$46.76 million03/27/2025$1.83$1.71-6.56%$1.82$1.6457,837 shs$47.04 million03/26/2025$1.85$1.83-1.08%$1.88$1.7512,323 shs$50.34 million03/25/2025$1.82$1.85+1.65%$1.90$1.7523,700 shs$50.89 million03/24/2025$1.80$1.82+1.11%$1.82$1.7714,901 shs$50.07 million03/21/2025$1.82$1.80-1.10%$1.87$1.7134,323 shs$49.51 million03/20/2025$1.95$1.82-6.67%$2.05$1.7569,215 shs$50.07 million03/19/2025$1.93$1.95+1.04%$2.06$1.90101,266 shs$53.64 million03/18/2025$1.73$1.93+11.56%$1.97$1.7383,768 shs$53.09 million Related Companies Eledon Pharmaceuticals Stock Chart Cardiff Oncology Stock Chart MediWound Stock Chart Tevogen Bio Stock Chart Voyager Therapeutics Stock Chart Genfit Stock Chart Inventiva Stock Chart Prime Medicine Stock Chart INmune Bio Stock Chart Inhibrx Stock Chart Receive IMMX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Immix Biopharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:IMMX) was last updated on 4/19/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immix Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Immix Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
